Iteos Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview

iTeos Therapeutics

02/08/2024 15:16

* Iteos Therapeutics Inc  ITOS.OQ   ITOS.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 6
(estimated) for the period ending January 1 0001
    * The Watertown Massachusetts-based  company is expected to
report
revenue of $1 million, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Iteos Therapeutics Inc
is for
a loss of $1.04 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $41.00​, above​ its last closing price
of $17.46. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.97       -1.26                        14.8
 Jan. 1 2024   -0.93       -1.03                        17.7
 Sep. 30 2023  -1.14       -1.20                        25.2​
 Jan. 1 0001   -0.98       -1.03      -0.96     Beat    55.8
 ​​Mar.        -1.00       -0.99      -0.44     Beat    55.8
 31 2023                                                
 Dec. 31 2022              0.33                         ​
 Sep. 30 2022  0.11        0.10       0.03      Missed  -69.2
 Jan. 1 0001   1.13        1.20       0.15      Missed  -87.5
 This summary was machine generated August 2 at 14:16 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)